- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04578769
Assessment of Different Modified POEM for Achalasia
Comparison Study of Conventional Peroral Endoscopic Myotomy (POEM) and Different Modified Procedures of POEM for Achalasia
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Peroral endoscopic myotomy (POEM) is a novel clinical technique used to treat achalasia. The conventional POEM myotomy length averages 8 to 10 cm (4-6 cm in the esophagus, 2-4cm in the LES, 2cm in the cardia & 6-8 cm above and 2 cm below the gastroesophageal junction [GEJ]) for typical achalasia (Chicago classification I, II), with only the inner circular muscle layer incised.
There is still no conclusion on the thickness of muscle bundle dissection recommended during POEM. Selective circular muscle myotomy is designed to avoid gastroesophageal reflux (GER) postoperatively and decrease morbidity during POEM. But one meta-analysis showed that Heller's surgery could keep patients in long-time remission, mainly because of its full-thickness muscle bundle dissection to make sure of persist relaxation of LES. A retrospective study comparing the outcomes of full-thickness and circular muscle myotomy showed no differences in efficacy, GER or adverse events, although the procedural time was shorter in the full thickness myotomy group.
Further randomized controlled trials are warranted to assess the efficacy and safety of different modified myotomy approaches in POEM for patients with achalasia.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Tao Guo, MD
- Phone Number: 8610-69155017
- Email: guoqiong990@126.com
Study Locations
-
-
Beijing Municipality
-
Beijing, Beijing Municipality, China, 100730
- Recruiting
- Department of Gastroenterology, Peking Union Medical College Hospital
-
Contact:
- Tao Guo, MD
- Phone Number: 8610-69155017
- Email: guoqiong990@126.com
-
Principal Investigator:
- Tao Guo, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- diagnosed as achalasia type I or II according to the Chicago Classification Version 4.0, with an Eckardt score >3
- Their age is ≥14years and ≤70 years
- Able to give written consent
Exclusion Criteria:
- undergone previous surgical treatments
- had contra-indication to general anesthesia
- previous surgery of the mediastinum, stomach, or esophagus;
- Pregnant or lactating female
- type III achalasia
- current alcohol or drug addiction, mental retardation, severe congenital or acquired coagulopathy (international normalized ratio >1.6)
- hepatic cirrhosis with or without portal hypertension, eosinophilic esophagitis (biopsies were performed at index endoscopy), or confirmed Barrett's esophagus
- esophageal diverticula or hiatal hernia based on findings from the index barium esophagram, or other conditions that the investigator believed not appropriate for POEM procedure
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: conventional myotomy
conventional myotomy for achalasia type I or II
|
Other Names:
|
|
Experimental: full-thickness myotomy
modified myotomy (full-thickness myotomy) for achalasia type I or II
|
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Therapeutic success of short term
Time Frame: 6 months after the procedure
|
Clinical severity was assessed using the Eckardt score.
This score is the sum of the symptom scores for dysphagia, regurgitation, and chest pain (with 0 indicating the absence of symptoms, 1 indicating occasional symptoms, 2 indicating daily symptoms, and 3 indicating symptoms at each meal) and weight loss (with 0 indicating no weight loss, 1 indicating a loss of <5 kg, 2 indicating a loss of 5 to 10 kg, and 3 indicating a loss of >10 kg).
The total score ranges from 0 to 12, with higher scores indicating more severe disease symptomatology.
(Eckardt, V. Gastroenterology, 1992.
103(6): 1732-8.
|
6 months after the procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of intra-procedure complications
Time Frame: During the endoscopic procedure
|
Complications encountered during the procedure will be noted.
(perforation, delayed bleeding, pneumothorax, subcutaneous emphysema, anastomotic leak etc.)
|
During the endoscopic procedure
|
|
Procedure time
Time Frame: During the endoscopic procedure
|
The duration of the endoscopic procedures for each patients will be calculated, in minutes, since the mucosal incision until the endoscopic closure of the mucosal entry with the last endoscopic clip.
|
During the endoscopic procedure
|
|
Pressure changes by high-resolution manometry (HRM)
Time Frame: 6 month after the procedure
|
Basal lower esophageal sphincter (LES) pressure, Distal contractile integral (DCI) and integrated relaxation pressure (IRP)
|
6 month after the procedure
|
|
barium esophagogram
Time Frame: 6 month after the procedure
|
Barium swallow studies will be done to evaluate the oesophageal emptying at 5 minutes and esophageal distortion
|
6 month after the procedure
|
|
the rate and severity of oesophagitis
Time Frame: 6 months after the procedure
|
oesphagitis was identified under esophagogastroduodenoscopy, and was classified according to the Los Angeles Classification
|
6 months after the procedure
|
|
perioperative hospitalization
Time Frame: perioperative period
|
perioperative hospitalization length
|
perioperative period
|
|
post-POEM persistent pain
Time Frame: postoperative period
|
Post-POEM persistent pain was defined as pain requiring level 2 or 3 analgesics.
|
postoperative period
|
|
(4) Esophagogastroduodenoscopy (EGD) with the novel Endoscopic Scoring for Achalasia (CARS)
Time Frame: 6-month after the procedure
|
Endoscopic evaluation was performed using the Contents, Anatomy, Resistance, and Stasis (CARS) score.
This scoring system was developed and validated through video-based reliability assessments and initially demonstrated strong clinical utility for predicting achalasia.
The score assigns 0 to 2 points each for Contents, Anatomy, and Resistance at the lower esophageal sphincter, and 1 point for each component of Stasis.
The total score ranges from 0 to 8, with higher scores indicating a worse endoscopic outcome.
|
6-month after the procedure
|
|
POEM difficulty evaluation
Time Frame: During the endoscopic procedure
|
① Peroral Endoscopic Myotomy (POEM) difficulty score (PDS).
The score consists of five variables: Fibrosis, Oozing, Orientation, Distension of tunnel, and Spastic contractions ("FOODS").
Each variable was arbitrarily weighted equally and assigned values ranging from 0 to 2. The PDS was completed immediately post-procedure in the operating room.
The total score ranges from 0 to 10, with higher scores indicating greater technical difficulty.
② bleeding episodes, classified into (1) none to minimal (2) moderate to diffuse
|
During the endoscopic procedure
|
Collaborators and Investigators
Investigators
- Principal Investigator: Tao Guo, MD, Peking Union Medical College Hospital
Publications and helpful links
General Publications
- Kane ED, Budhraja V, Desilets DJ, Romanelli JR. Myotomy length informed by high-resolution esophageal manometry (HREM) results in improved per-oral endoscopic myotomy (POEM) outcomes for type III achalasia. Surg Endosc. 2019 Mar;33(3):886-894. doi: 10.1007/s00464-018-6356-0. Epub 2018 Jul 27.
- Kahrilas PJ, Bredenoord AJ, Fox M, Gyawali CP, Roman S, Smout AJ, Pandolfino JE; International High Resolution Manometry Working Group. The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil. 2015 Feb;27(2):160-74. doi: 10.1111/nmo.12477. Epub 2014 Dec 3.
- Inoue H, Shiwaku H, Kobayashi Y, Chiu PWY, Hawes RH, Neuhaus H, Costamagna G, Stavropoulos SN, Fukami N, Seewald S, Onimaru M, Minami H, Tanaka S, Shimamura Y, Santi EG, Grimes K, Tajiri H. Statement for gastroesophageal reflux disease after peroral endoscopic myotomy from an international multicenter experience. Esophagus. 2020 Jan;17(1):3-10. doi: 10.1007/s10388-019-00689-6. Epub 2019 Sep 26.
- Inoue H, Shiwaku H, Iwakiri K, Onimaru M, Kobayashi Y, Minami H, Sato H, Kitano S, Iwakiri R, Omura N, Murakami K, Fukami N, Fujimoto K, Tajiri H. Clinical practice guidelines for peroral endoscopic myotomy. Dig Endosc. 2018 Sep;30(5):563-579. doi: 10.1111/den.13239.
- Wang J, Tan N, Xiao Y, Chen J, Chen B, Ma Z, Zhang D, Chen M, Cui Y. Safety and efficacy of the modified peroral endoscopic myotomy with shorter myotomy for achalasia patients: a prospective study. Dis Esophagus. 2015 Nov-Dec;28(8):720-7. doi: 10.1111/dote.12280. Epub 2014 Sep 12.
- Li L, Chai N, Linghu E, Li Z, Du C, Zhang W, Zou J, Xiong Y, Zhang X, Tang P. Safety and efficacy of using a short tunnel versus a standard tunnel for peroral endoscopic myotomy for Ling type IIc and III achalasia: a retrospective study. Surg Endosc. 2019 May;33(5):1394-1402. doi: 10.1007/s00464-018-6414-7. Epub 2018 Sep 5.
- Wang XH, Tan YY, Zhu HY, Li CJ, Liu DL. Full-thickness myotomy is associated with higher rate of postoperative gastroesophageal reflux disease. World J Gastroenterol. 2016 Nov 14;22(42):9419-9426. doi: 10.3748/wjg.v22.i42.9419.
- Li QL, Chen WF, Zhou PH, Yao LQ, Xu MD, Hu JW, Cai MY, Zhang YQ, Qin WZ, Ren Z. Peroral endoscopic myotomy for the treatment of achalasia: a clinical comparative study of endoscopic full-thickness and circular muscle myotomy. J Am Coll Surg. 2013 Sep;217(3):442-51. doi: 10.1016/j.jamcollsurg.2013.04.033. Epub 2013 Jul 25.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PUMCH-POEM-1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Esophageal Achalasia
-
Federico II UniversityRecruitingAchalasia | Indocyanine Green | Indocyanine Green (ICG) | Achalasia, EsophagealItaly
-
Baylor College of MedicineRecruitingEsophageal Motility Disorders | AchalasiaUnited States
-
Mayo ClinicTerminatedAchalasia | Esophageal Achalasia | Achalasia, EsophagealUnited States
-
Peking Union Medical College HospitalCompleted
-
Assiut UniversityNot yet recruiting
-
Cairo UniversityRecruitingAchalasia | Achalasia CardiaEgypt
-
Federico II UniversityCompleted
-
Asian Institute of Gastroenterology, IndiaCompleted
-
Asian Institute of Gastroenterology, IndiaNot yet recruiting
-
The First Affiliated Hospital of Zhengzhou UniversityRecruitingDysphagia | Cricopharyngeal AchalasiaChina
Clinical Trials on conventional myotomy
-
Nanfang Hospital of Southern Medical UniversityUnknownEsophageal Motility Disorders | Esophageal AchalasiaChina
-
Northwestern UniversityCompleted
-
Northwestern UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingType I Achalasia | Type II Achalasia | EGJ Outflow Obstruction Without Spastic/Hypercontractile FeaturesUnited States
-
Massachusetts General HospitalCompleted
-
Asian Institute of Gastroenterology, IndiaNot yet recruiting
-
The Oregon ClinicCompleted
-
Karolinska University HospitalErsta Hospital, SwedenCompleted
-
Asian Institute of Gastroenterology, IndiaRecruiting
-
Asan Medical CenterUnknown
-
Asian Institute of Gastroenterology, IndiaRecruitingEsophageal DiseasesIndia